Literature DB >> 1726657

Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission.

M L Gruber1, F H Hochberg.   

Abstract

Episodic cerebro or retinovascular ischemic events without apparent cause occur in patients with cancer. We report a patient in remission from lymphoma whose multiple episodes of presumed ocular ischemia occurred in the setting of a circulating lupus anticoagulant. Symptoms resolved following therapy with Warfarin.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1726657     DOI： 10.1007/bf00165534

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  13 in total

1.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

2.  The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.

Authors:  M Petri; M Rheinschmidt; Q Whiting-O'Keefe; D Hellmann; L Corash
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

Review 3.  The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies.

Authors:  S R Levine; K M Welch
Journal:  Arch Neurol       Date:  1987-08

Review 4.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

5.  Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.

Authors:  D Green; C Hougie; F J Kazmier; K Lechner; P M Mannucci; C R Rizza; Y Sultan
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

6.  "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.

Authors:  L O Carreras; J G Vermylen
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

7.  Amaurosis fugax associated with antiphospholipid antibodies.

Authors:  K B Digre; F J Durcan; D W Branch; D M Jacobson; M W Varner; J R Baringer
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

8.  Neurological disease associated with antiphospholipid antibodies.

Authors:  D P Briley; B M Coull; S H Goodnight
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

9.  Episodic neurologic dysfunction in patients with Hodgkin's disease.

Authors:  E Feldmann; J B Posner
Journal:  Arch Neurol       Date:  1986-12

10.  The relationship between lupus anticoagulants and antibodies to phospholipid.

Authors:  D A Triplett; J T Brandt; K A Musgrave; C A Orr
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272
View more
  1 in total

1.  Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Authors:  E Zuckerman; E Toubi; T D Golan; T Rosenvald-Zuckerman; E Sabo; Z Shmuel; D Yeshurun
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.